You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
18 March 2025 - Biopharmaceutical company RedHill Biopharma Ltd (Nasdaq:RDHL) said on Tuesday that it plans to submit a UK Marketing Authorisation Application (MAA) for Talicia, a treatment for Helicobacter pylori (H. pylori) infection, using the Med...
18 March 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Tuesday that it has received US Food and Drug Administration (FDA) 510(k) clearance for its VITEK COMPACT PRO system.The new system enhances microorganism ...
18 March 2025 - The cancer diagnostics company BiBBInstruments AB announced on Tuesday the successful use of EndoDrill GI during a live broadcasted biopsy procedure at Hospital Pedro Hispano in Porto, Portugal.The procedure, which involved sampling a...
18 March 2025 - Clinical stage biotechnology company Evommune Inc announced on Monday that the first patient has been enrolled in a Phase 2 trial of EVO301 in adults with moderate-to-severe atopic dermatitis (AD).EVO301 is a serum albumin Fab-associa...
18 March 2025 - Australian clinical stage biotechnology company Telix Pharmaceuticals Limited (ASX:TLX) (Nasdaq:TLX) announced on Tuesday that it has received approval from the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanita...
17 March 2025 - Hemogenyx Pharmaceuticals plc (LSE: HEMO) announced on Monday that it has recruited a second patient for its clinical trial of HG-CT-1, a proprietary CAR-T cell therapy for relapsed or refractory acute myeloid leukemia (R/R AML) in ad...
17 March 2025 - Physiomics plc (AIM: PYC) announced on Monday that it has secured a contract with a UK-based biotech company developing antibody-drug conjugate (ADC) therapies for hard-to-treat cancers.The GBP102,000 project will run from April to Au...